131 related articles for article (PubMed ID: 21043990)
41. Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia.
Ge CJ; Lu SZ; Chen YD; Wu XF; Hu SJ; Ji Y
Heart Vessels; 2008 Mar; 23(2):91-5. PubMed ID: 18389332
[TBL] [Abstract][Full Text] [Related]
42. Atorvastatin affects TLR4 clustering via lipid raft modulation.
Chansrichavala P; Chantharaksri U; Sritara P; Ngaosuwankul N; Chaiyaroj SC
Int Immunopharmacol; 2010 Aug; 10(8):892-9. PubMed ID: 20472098
[TBL] [Abstract][Full Text] [Related]
43. Atorvastatin ameliorates tissue damage of obstructed ureter in rats.
Chuang YH; Chuang WL; Huang SP; Liu CK; Huang CH
Life Sci; 2011 Nov; 89(21-22):795-805. PubMed ID: 21971118
[TBL] [Abstract][Full Text] [Related]
44. Comparative effects of HMG-CoA reductase inhibitors on apo B production in the casein-fed rabbit: atorvastatin versus lovastatin.
Auerbach BJ; Krause BR; Bisgaier CL; Newton RS
Atherosclerosis; 1995 Jun; 115(2):173-80. PubMed ID: 7661876
[TBL] [Abstract][Full Text] [Related]
45. Up-regulating PPAR-γ expression and NO concentration, and down-regulating PAI-1 concentration in a rabbit atherosclerotic model: the possible antiatherogenic and antithrombotic effects of atorvastatin.
Yang P; Li Y; Li JJ; Qin L; Li XY
Int J Cardiol; 2010 Mar; 139(3):213-7. PubMed ID: 19307033
[TBL] [Abstract][Full Text] [Related]
46. Atorvastatin reduces expression of leukocyte adhesion molecules in patients with hypercholesterolemia.
Stulc T; Vrablík M; Kasalová Z; Ceska R; Marinov I
Atherosclerosis; 2003 Jan; 166(1):197-8. PubMed ID: 12482568
[No Abstract] [Full Text] [Related]
47. Atorvastatin attenuates involvement of RhoA/Rho-kinase pathway and NF-κB activation in hypoxic pulmonary hypertensive rats.
Zhang Y; Dai L; Wu S; Chen P; Zhao S
Chin Med J (Engl); 2014; 127(5):869-72. PubMed ID: 24571879
[TBL] [Abstract][Full Text] [Related]
48. Statins attenuate high mobility group box-1 protein induced vascular endothelial activation : a key role for TLR4/NF-κB signaling pathway.
Yang J; Huang C; Yang J; Jiang H; Ding J
Mol Cell Biochem; 2010 Dec; 345(1-2):189-95. PubMed ID: 20714791
[TBL] [Abstract][Full Text] [Related]
49. Effect of atorvastatin on tumor necrosis factor alpha serum concentration and mRNA expression of adipose in hypercholesterolemic rabbits.
Zhao SP; Wu ZH; Wu J; Hong SC; Deng P
J Cardiovasc Pharmacol; 2005 Aug; 46(2):185-9. PubMed ID: 16044030
[TBL] [Abstract][Full Text] [Related]
50. Effects of atorvastatin on expression of ICAM-1 in atherosclerotic rabbits.
Du B; Xu G; Cao H; Cui W; Lin S; Liu Y; Qin L
J Cardiovasc Med (Hagerstown); 2013 Feb; 14(2):120-6. PubMed ID: 22609871
[TBL] [Abstract][Full Text] [Related]
51. Effect of atorvastatin on atherosclerotic plaque formation and platelet activation in hypercholesterolemic rats.
Gocmen AY; Ocak GA; Ozbilim G; Delibas N; Gumuslu S
Can J Physiol Pharmacol; 2013 Sep; 91(9):680-5. PubMed ID: 23984971
[TBL] [Abstract][Full Text] [Related]
52. Atorvastatin and diabetic vascular complications.
Yamagishi S; Matsui T; Nakamura K
Curr Pharm Des; 2006; 12(12):1549-54. PubMed ID: 16611135
[TBL] [Abstract][Full Text] [Related]
53. The effect of atorvastatin on platelet function in patients with coronary artery disease.
Tekten T; Ceyhan C; Ercan E; Onbasili AO; Turkoglu C
Acta Cardiol; 2004 Jun; 59(3):311-5. PubMed ID: 15255464
[TBL] [Abstract][Full Text] [Related]
54. Short-term effects of atorvastatin on bone turnover in male patients with hypercholesterolemia.
Majima T; Komatsu Y; Fukao A; Ninomiya K; Matsumura T; Nakao K
Endocr J; 2007 Feb; 54(1):145-51. PubMed ID: 17185879
[TBL] [Abstract][Full Text] [Related]
55. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase the binding activity and nuclear level of Oct-1 in mononuclear cells.
Ortego M; Hernández AG; Bustos C; Blanco-Colio LM; Hernández-Presa MA; Tuñón J; Egido J
Eur J Pharmacol; 2002 Jul; 448(2-3):113-21. PubMed ID: 12144930
[TBL] [Abstract][Full Text] [Related]
56. Atorvastatin induces thrombomodulin expression in the aorta of cholesterol-fed rabbits and in TNFalpha-treated human aortic endothelial cells.
Lin SJ; Hsieh FY; Chen YH; Lin CC; Kuan II; Wang SH; Wu CC; Chien HF; Lin FY; Chen YL
Histol Histopathol; 2009 Sep; 24(9):1147-59. PubMed ID: 19609862
[TBL] [Abstract][Full Text] [Related]
57. Effects of atorvastatin therapy on protein oxidation and oxidative DNA damage in hypercholesterolemic rabbits.
Aydin S; Uzun H; Sozer V; Altug T
Pharmacol Res; 2009 Apr; 59(4):242-7. PubMed ID: 19429465
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of statin therapy on endothelial function in hypercholesterolemic rabbits by automatic measurement of arterial wall movement using ultrasound images.
Rahmani-Cherati T; Mokhtari-Dizaji M; Vajhi A; Rostami A
Ultrasound Med Biol; 2014 Oct; 40(10):2415-24. PubMed ID: 25018028
[TBL] [Abstract][Full Text] [Related]
59. Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells.
Hernández-Presa MA; Martín-Ventura JL; Ortego M; Gómez-Hernández A; Tuñón J; Hernández-Vargas P; Blanco-Colio LM; Mas S; Aparicio C; Ortega L; Vivanco F; Gerique JG; Díaz C; Hernández G; Egido J
Atherosclerosis; 2002 Jan; 160(1):49-58. PubMed ID: 11755922
[TBL] [Abstract][Full Text] [Related]
60. Effect of monthly atorvastatin treatment on hemostasis.
Okopien B; Krysiak R; Herman ZS
Int J Clin Pharmacol Ther; 2004 Nov; 42(11):589-93. PubMed ID: 15598024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
